Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer.

Use of hydrochlorothiazide was associated with an increased risk of cSCC and with evidence of a duration- and dose-response relationship. In contrast, no association was observed for BCC or melanoma.